HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monika Patre Selected Research

Breast Neoplasms (Breast Cancer)

3/2024Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
12/2021Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
10/2020Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial.
11/2019Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
5/2019Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
1/2019Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
1/2019Pharmacokinetics of trastuzumab emtansine (T-DM1) as a single agent or in combination with pertuzumab in HER2-positive breast cancer patients with recurrent or locally advanced metastatic breast cancer.
1/2017Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monika Patre Research Topics

Disease

8Breast Neoplasms (Breast Cancer)
03/2024 - 01/2017
3Neoplasms (Cancer)
03/2024 - 11/2019
1Disease Progression
03/2024
1Thrombocytopenia (Thrombopenia)
10/2020
1Neutropenia
10/2020

Drug/Important Bio-Agent (IBA)

7Ado-Trastuzumab EmtansineIBA
12/2021 - 01/2017
6Trastuzumab (Herceptin)FDA Link
12/2021 - 01/2017
6pertuzumabIBA
12/2021 - 01/2017
5taxaneIBA
10/2020 - 01/2017
3ErbB Receptors (EGF Receptor)IBA
12/2021 - 01/2017
3Tumor Biomarkers (Tumor Markers)IBA
11/2019 - 01/2019
2atezolizumabIBA
12/2021 - 10/2020
2human ERBB2 proteinIBA
11/2019 - 01/2019
1giredestrantIBA
03/2024
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
03/2024
1Fulvestrant (Faslodex)FDA Link
03/2024
1Aromatase InhibitorsIBA
03/2024
1Estrogen ReceptorsIBA
03/2024
1Docetaxel (Taxotere)FDA Link
12/2021
1Biomarkers (Surrogate Marker)IBA
12/2021
1Carboplatin (JM8)FDA LinkGeneric
12/2021
1B7-H1 AntigenIBA
12/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2020
1Alanine Transaminase (SGPT)IBA
10/2020

Therapy/Procedure

5Therapeutics
03/2024 - 01/2017
1Drug Therapy (Chemotherapy)
03/2024
1Immunotherapy
12/2021